Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT observational study of immunogenicity of therapeutic antibodies
jRCT1011220023Recruiting
- Sponsor
- Sapporo Medical University Hospital
- Start
- Oct 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in inflammatory bowel disease (IBD), psoriasis, Palmoplantar Pustular Psoriasis (PPPP) and 4 more, sponsored by Sapporo Medical University Hospital. Primary endpoint: Rate of anti-drug antibody (ADA) development. Started Oct 2022; status: recruiting.
02
Conditions
inflammatory bowel disease (IBD)psoriasisPalmoplantar Pustular Psoriasis (PPPP)cancermelanoma
Beyond the preview
Go deeper on jRCT1011220023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011220023.